Fingolimod 0.5 mg an optimal therapy for relapsing-remitting MS
16 Oct 2020
byAudrey Abella
The 0.5-mg dose of fingolimod has a superior benefit-risk profile over the 0.25-mg dose, and was superior to glatiramer acetate (GA) – a widely used, effective drug for multiple sclerosis (MS), for treating adults with relapsing or remitting forms of MS (RRMS), the ASSESS study has shown.